Rutaretin1'-(6″-sinapoylglucoside): promising inhibitor of COVID 19 m

Humans COVID-19 Rosales COVID-19 Drug Treatment Lopinavir Molecular Docking Simulation Molecular Dynamics Simulation Protease Inhibitors
3CLpro COVID-19 LC-HRMS MD simulations Pittosporum dasycaulon molecular docking

Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
2022
Historique:
pubmed: 17 9 2021
medline: 28 12 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

SARS CoV2 is a novel strain of coronavirus, first reported in Wuhan of China, in 2019 and drugs specific to COVID-19 treatment are still lacking. The main protease (3CL) present in the new coronavirus strain is considered a potential drug target due to its role in viral replications. The plant

Identifiants

DOI: 10.1080/07391102.2021.1972841 PMID: 34528865
pubmed: 34528865
doi: 10.1080/07391102.2021.1972841
doi:

Substances chimiques

Lopinavir 2494G1JF75
Protease Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12557-12573

Auteurs

Riyas Chakkinga Thodi (RC)

Department of Botany, University of Kerala, Kariavattom, Kerala, India.

Junaida M Ibrahim (JM)

Department of Computational Biology & Bioinformatics, University of Kerala, Kariavattom, Kerala, India.

Vivek Arinchedathu Surendran (VA)

Department of Botany, University of Kerala, Kariavattom, Kerala, India.

Achuthsankar S Nair (AS)

Department of Computational Biology & Bioinformatics, University of Kerala, Kariavattom, Kerala, India.

Swapna Thacheril Sukumaran (ST)

Department of Botany, University of Kerala, Kariavattom, Kerala, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Eucaryotes › Viridiplantae › Streptophyta › Embryophyta › Tracheobionta › Magnoliopsida › Rosanae › Rosales › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Traitements médicamenteux de la COVID-19 › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyrimidines › Pyrimidinones › Lopinavir › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Simulation numérique › Simulation de docking moléculaire › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Simulation numérique › Simulation de dynamique moléculaire › Rutaretin1'-(6″-sinapoylglucoside): promising...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de protéases › Rutaretin1'-(6″-sinapoylglucoside): promising...